BUY Nestle India Limited — Manas Jaiswal
byManas JaiswalHorizon: 1 year6 May 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Nestle India reported strong financial results for the quarter ended September 30, 2026, with total sales of INR 6,782.2 crore, reflecting a 20.5% growth driven by double-digit volume growth.
BSE · Board Meeting·15 Oct · today
7 other SEBI-registered advisors have active long-term BUY calls on this stock
Advisor consensus · same horizon·22 Sept · 3w ago
FMCG Stocks Surge: Nestle India, ITC, HUL, Patanjali Foods Shares Jump Over 3%
NewsNdtv-Profit·16 Sept · 4w ago
Nestle India Shares Jump Over 2% On Nuvama's Bullish Growth Forecast, 'Buy' Rating
NewsNdtv-Profit·16 Sept · 4w ago
1 advisor has an active short-term BUY call on this stock
Advisor consensus · adjacent horizon·16 Sept · 4w ago
Nestle India faced FSSAI cases as Nestle India stock sits 13.93 percent below its high
NewsGoogle News·9 Oct · 5d ago
Nestlé India Joint Venture Faces FSSAI Notice Over Celevida GLP+
NewsGoogle News·9 Oct · 5d ago
1 other SEBI-registered advisor has an active long-term SELL call on this stock
Advisor consensus · same horizon·30 Sept · 2w ago
'Can't Comment On Authenticity': Nestle India Responds After Insects Reportedly Found In Maggi
NewsNdtv-Profit·27 Sept · 2w ago
Nestle India issues clarification: Why FMCG stock plunged? What's FSSAI baby formula row; why it matters to consumers?
NewsLivemint·19 Sept · 4w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Nestle India
- BUY — Axis Securities16 Oct 2026 · ~1 year · target ₹1,470 · Active
- BUY — BOB Capital Markets16 Oct 2026 · ~1 year · target ₹1,755 · Active
- BUY — ICICI Securities16 Oct 2026 · ~1 year · target ₹1,600 · Active
- BUY — Elara Capital16 Oct 2026 · ~1 year · target ₹1,506 · Active
- BUY — Ashish Bahety, Profitmart Securities15 Oct 2026 · Same day · target ₹1,420 · SL hit
More from Manas Jaiswal
- BUY Ajanta Pharma23 Oct 2026 · Same day · target ₹3,425 · SL hit
- BUY Torrent Pharmaceuticals23 Oct 2026 · Same day · target ₹4,725 · SL hit
- BUY SAGILITY23 Oct 2026 · ~2 weeks · target ₹50 · SL hit
- BUY Zydus Lifesciences22 Oct 2026 · ~3 months · target ₹1,160 · SL hit
- BUY IPCA Laboratories22 Oct 2026 · ~2 weeks · target ₹2,000 · Active

